LifeStance Health Group, Inc. Interest Expense
LifeStance Health Group, Inc. (LFST) reported Interest Expense of $2.63 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-06
- LifeStance Health Group, Inc. interest expense for the quarter ending 2026-06-30 was $2.63M, a 9.24% decline year-over-year.
- LifeStance Health Group, Inc. interest expense for the quarter ending 2026-03-31 was $1.79M, a 41.65% decline year-over-year.
- LifeStance Health Group, Inc. interest expense for the quarter ending 2025-12-31 was $2.88M, a 69.40% decline year-over-year.
- LifeStance Health Group, Inc. interest expense for the quarter ending 2025-09-30 was $2.81M, a 48.01% decline year-over-year.
- LifeStance Health Group, Inc. interest expense for fiscal 2025 was $11.66M, a 56.05% decline from fiscal 2024.
- LifeStance Health Group, Inc. interest expense for fiscal 2024 was $26.54M, a 25.05% increase from fiscal 2023.
- LifeStance Health Group, Inc. interest expense for fiscal 2023 was $21.22M, a 6.48% increase from fiscal 2022.
- LifeStance Health Group, Inc. interest expense for fiscal 2022 was $19.93M, a 48.79% decline from fiscal 2021.
| Period end | Interest Expense 1 month | Interest Expense 3 month | Interest Expense 4 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2.63M 10-Q · filed 2026-08-06 | $4.42M 10-Q · filed 2026-08-06 | $7.30M derived: sum of 3 quarters · filed 2026-08-06 | $10.11M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $1.79M 10-Q · filed 2026-05-07 | $4.67M derived: sum of 2 quarters · filed 2026-05-07 | $7.48M derived: sum of 3 quarters · filed 2026-05-07 | $10.38M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $5.69M derived: sum of 2 quarters · filed 2026-02-25 | $8.59M derived: sum of 3 quarters · filed 2026-08-06 | $11.66M 10-K · filed 2026-02-25 | ||
| 2025-09-30 | $2.81M 10-Q · filed 2025-11-06 | $5.71M derived: sum of 2 quarters · filed 2026-08-06 | $8.79M 10-Q · filed 2025-11-06 | $18.18M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $2.90M 10-Q · filed 2026-08-06 | $5.97M 10-Q · filed 2026-08-06 | $15.37M derived: sum of 3 quarters · filed 2026-08-06 | $20.78M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $3.07M 10-Q · filed 2026-05-07 | $12.47M derived: sum of 2 quarters · filed 2026-05-07 | $17.88M derived: sum of 3 quarters · filed 2026-05-07 | $23.70M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $9.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $14.81M derived: sum of 2 quarters · filed 2026-02-25 | $20.63M derived: sum of 3 quarters · filed 2026-02-25 | $26.54M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $5.41M 10-Q · filed 2025-11-06 | $11.24M derived: sum of 2 quarters · filed 2025-11-06 | $17.14M 10-Q · filed 2025-11-06 | $22.67M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | $5.82M 10-Q · filed 2025-08-07 | $11.73M 10-Q · filed 2025-08-07 | $17.26M derived: sum of 3 quarters · filed 2026-02-25 | $22.73M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | $5.90M 10-Q · filed 2025-05-07 | $11.44M derived: sum of 2 quarters · filed 2026-02-25 | $16.91M derived: sum of 3 quarters · filed 2026-02-25 | $22.03M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | $5.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $11.01M derived: sum of 2 quarters · filed 2026-02-25 | $16.13M derived: sum of 3 quarters · filed 2026-02-25 | $21.22M 10-K · filed 2026-02-25 | ||
| 2023-09-30 | $5.48M 10-Q · filed 2024-11-07 | $10.60M derived: sum of 2 quarters · filed 2024-11-07 | $15.69M 10-Q · filed 2024-11-07 | $20.85M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $5.12M 10-Q · filed 2024-08-08 | $10.21M 10-Q · filed 2024-08-08 | $15.38M derived: sum of 3 quarters · filed 2025-02-27 | $19.57M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $5.09M 10-Q · filed 2024-05-09 | $10.26M derived: sum of 2 quarters · filed 2025-02-27 | $14.45M derived: sum of 3 quarters · filed 2025-02-27 | $21.58M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $5.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $9.35M derived: sum of 2 quarters · filed 2025-02-27 | $16.49M derived: sum of 3 quarters · filed 2025-02-27 | $19.93M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $4.19M 10-Q · filed 2023-11-08 | $11.32M derived: sum of 2 quarters · filed 2023-11-08 | $14.76M 10-Q · filed 2023-11-08 | $18.36M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $7.13M 10-Q · filed 2023-08-09 | $10.57M 10-Q · filed 2023-08-09 | $14.18M derived: sum of 3 quarters · filed 2024-02-28 | $17.68M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $3.44M 10-Q · filed 2023-05-10 | $7.04M derived: sum of 2 quarters · filed 2024-02-28 | $10.55M derived: sum of 3 quarters · filed 2024-02-28 | $33.72M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $7.11M derived: sum of 2 quarters · filed 2024-02-28 | $30.28M derived: sum of 3 quarters · filed 2024-02-28 | $38.91M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $3.50M 10-Q · filed 2022-11-09 | $26.68M derived: sum of 2 quarters · filed 2022-11-09 | $35.31M 10-Q · filed 2022-11-09 | $42.44M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-06-30 | $23.17M 10-Q · filed 2022-08-10 | $31.81M 10-Q · filed 2022-08-10 | $38.94M derived: sum of 3 quarters · filed 2023-03-09 | $45.36M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-03-31 | $8.63M 10-Q · filed 2022-05-11 | $15.76M derived: sum of 2 quarters · filed 2023-03-09 | $22.18M derived: sum of 3 quarters · filed 2023-03-09 | $27.74M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2020-12-31 | $7.13M derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-09 | $13.55M derived: sum of 2 quarters · filed 2023-03-09 | $19.11M 10-K · filed 2023-03-09 | |||
| 2020-09-30 | $6.42M 10-Q · filed 2021-11-10 | $11.98M 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | $5.56M 10-Q · filed 2021-08-12 | |||||
| 2020-05-14 | $1.34M 10-Q · filed 2021-08-12 | $3.02M 10-K · filed 2023-03-09 | ||||
| 2019-12-31 | $5.41M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |